Market›Health Care›Biotechnology›Biotechnology
KORRO BIO INC

KRRO

$12.89Apr 26, 2021 – Apr 24, 2026
Health CareBiotechnology$195M
MVM
+$4.2M
TD Variance
0.862

Every news event mapped to its market reaction — 106 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-11-13-79.0%earningsSeeking AlphaKorro Bio GAAP EPS of -$1.92, revenue of $1M
2025-11-13-79.0%earningsSeeking AlphaKorro Bio stock fell after missing expectations in early stage KRRO-110 trial
2025-11-13-79.0%executiveInvesting.comKorro Bio stock downgraded by RBC Capital on disappointing human data - Investing.com
2025-11-13-79.0%newsInvestor's Business DailyKorro Bio Plummets To A Record Low On A Big Setback In RNA Editing - Investor's Business Daily
2025-11-13-79.0%analystInvesting.comKorro Bio stock rating downgraded to Market Perform by William Blair - Investing.com
2025-11-13-79.0%analystInvesting.comH.C. Wainwright downgrades Korro Bio stock rating to Neutral on failed therapy - Investing.com
2025-11-13-79.0%earningsSeeking AlphaKorro Bio stock fell after missing expectations in early stage KRRO-110 trial - Seeking Alpha
2025-11-13-79.0%analystInvesting.comClear Street downgrades Korro Bio stock rating after AATD program setback - Investing.com
2025-11-13-79.0%M&ABioSpaceKorro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal - BioSpace
2025-11-13-79.0%executiveFierce BiotechKorro lays off 34% of staff as lead drug disappoints and Novo Nordisk pauses pact - Fierce Biotech
2025-11-13-79.0%newsBenzingaKorro Bio Early Trial Results Fall Short; Stock Hits New Low - Benzinga
2025-11-13-79.0%newsStocksToTradeKRRO’s Sudden Decline: Time to Re-evaluate? - StocksToTrade
2025-11-13-79.0%newsThe Business JournalsKorro Bio stock crashes as it cuts 34% of workforce due to clinical trial fail - The Business Journals
2025-11-12-78.6%earningsYahoo FinanceKorro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
2025-11-12-78.6%newsInvesting.comKorro Bio stock plummets after mixed AATD trial results - Investing.com
2025-11-12-78.6%newsStock TitanKorro Bio (Nasdaq: KRRO) cuts workforce 34%, extends cash runway into H2 2027 - Stock Titan
2025-11-12-78.6%newsTipRanksKorro Bio Pauses Novo Nordisk Collaboration Amid Restructuring - TipRanks
2025-11-12-78.6%earningsparameter.ioKorro Bio, Inc. (KRRO) Stock: Drop in Q3 Losses and Workforce Reduction Amid Drug Development Delays - parameter.io
2023-11-06+63.6%newsTradingViewTechnical Analysis of Korro Bio, Inc. (NASDAQ:KRRO) - TradingView
2025-07-22+25.4%analystInvesting.com South AfricaKorro Bio stock steady as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com South Africa
2025-08-12+24.4%earningsSeeking AlphaKorro Bio GAAP EPS of -$2.74 misses by $0.18
2026-01-28+24.1%analystSeeking AlphaKorro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow
2026-01-28+24.1%analystInvesting.comCantor Fitzgerald upgrades Korro Bio stock to Overweight on UCD program - Investing.com
2026-01-28+24.1%analystInvesting.comWilliam Blair reiterates Market Perform rating on Korro Bio stock - Investing.com
2024-11-13-23.1%earningsSeeking AlphaKorro Bio GAAP EPS of -$2.26
2023-11-10+22.1%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2024-08-14+22.0%earningsSeeking AlphaKorro Bio GAAP EPS of -$2.43 beats by $0.29
2024-03-26+19.9%earningsSeeking AlphaKorro Bio GAAP EPS of -$53.08
2026-01-29+14.5%analystSeeking AlphaKorro Bio, Inc. (KRRO) Analyst/Investor Day Transcript
2026-01-29+14.5%analystInvesting.comKorro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential - Investing.com
2026-01-29+14.5%analystInvesting.comPiper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment - Investing.com
2026-01-29+14.5%analystStocktwitsKRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism? - Stocktwits
2026-01-29+14.5%analystBenzingaThis Fortinet Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
2026-01-29+14.5%analystBenzingaMeta Platforms To Rally More Than 71%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
2025-05-08+11.1%newsIntellectia AIKRRO Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
2023-12-07-11.0%newsStock TitanLatest KRRO News - Korro Announces Selection of its First Deve... - Stock Titan
2026-03-12+10.9%earningsZacksKorro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates
2026-03-12+10.9%newsGlobeNewswireKorro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2026-03-12+10.9%earningsSeeking AlphaKorro Bio GAAP EPS of -$12.48 misses by $3.43, revenue of $6.4M beats by $1M
2026-03-12+10.9%earningsYahoo FinanceKorro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
2026-03-12+10.9%newsInvesting.comKorro Bio investor buys $2.3 million in KRRO stock By Investing.com - Investing.com
2026-03-12+10.9%newsInvesting.comNea 17 buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
2026-03-12+10.9%newsInvesting.comBaskett Forest buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
2024-11-21+10.4%newsSeeking AlphaKorro gets Australian HREC approval to initiate phase 1/2a study for antitrypsin deficiency
2025-03-19-10.2%earningsSeeking AlphaKorro Bio GAAP EPS of -$9.37 beats by $0.77, revenue of $2.27M
2025-03-19-10.2%newsYahoo FinanceIs Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth? - Yahoo Finance
2024-07-03+9.3%newsSeeking AlphaKorro Bio: Interesting RNA Biotech With 2nd Half 2025 Interim Data
2026-03-13+9.1%analystMT NewswiresRaymond James Upgrades Korro Bio to Outperform From Market Perform, Price Target is $23
2026-03-13+9.1%analystInvesting.comCantor Fitzgerald raises Korro Bio stock price target on UCD confidence - Investing.com
2026-03-13+9.1%analystInvesting.comRaymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com
2026-03-13+9.1%analystBenzingaKorro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook - Benzinga
2026-03-13+9.1%analystMSNRaymond James upgrades Korro Bio (KRRO) - MSN
2026-01-20+8.8%newsSeeking AlphaKorro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2026-01-20+8.8%newsSeeking AlphaKorro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2026-04-02+8.4%newsInvesting.comLynx1 Capital buys Korro Bio (KRRO) shares worth $5512 - Investing.com
2026-04-02+8.4%newsStock TitanFund linked to Korro Bio (KRRO) reports 1.54M shares on Form 3 - Stock Titan
2026-04-02+8.4%newsStock TitanLynx1 fund tied to Weston Nichols adds Korro Bio (KRRO) position - Stock Titan
2026-04-23-8.2%earningsCổng thông tin điện tử tỉnh Lào CaiKorro Bio (KRRO) Moat Analysis | Q4 2025: Earnings Beat Estimates - Expert Momentum Signals - Cổng thông tin điện tử tỉnh Lào Cai
2025-10-23-7.6%newssimplywall.stWill Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely? - simplywall.st
2024-02-18+7.4%newsSeeking AlphaKorro Bio: An Interesting Platform With A Very Long Horizon
2023-11-28+7.1%newsStock TitanLatest KRRO News - Korro Announces Oral and Poster Presentatio... - Stock Titan
2026-04-11+7.0%newsThe Manila TimesKorro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
2025-08-26+6.9%newsYahoo FinanceIs Korro Bio (NASDAQ:KRRO) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
2024-02-27-6.4%analystSeeking AlphaBMO starts Korro at outperform, cites upcoming data for AATD drug
2025-09-17+6.3%newsInvesting.comKorro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal phase - Investing.com
2023-09-24-5.9%analystBenzingaKorro Bio Analyst Ratings and Price Targets | NASDAQ:KRRO - Benzinga
2024-07-20+5.1%newsTradingViewKRRO Stock Price and Chart — NASDAQ:KRRO - TradingView
2023-11-29+4.7%earningsZacks Investment ResearchWhat date does Korro Bio, Inc.'s (KRRO) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research
2025-10-08-4.5%executiveInvesting.comKorro Bio CFO Vineet Agarwal to step down, CEO Ram Aiyar named interim CFO - Investing.com
2025-11-14-4.4%newsYahoo FinanceKorro Bio (KRRO): Assessing Valuation After Clinical Setbacks, Layoffs, and Strategic Pivot - Yahoo Finance
2025-11-14-4.4%earningssimplywall.stWhy Korro Bio (KRRO) Is Down 80.0% After Restructuring, Clinical Trial Miss, and CMO Resignation - simplywall.st
2026-03-10-4.1%newsZacksUnited Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?
2025-11-11-4.0%analystStocktwitsKorro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup - Stocktwits
2025-03-28-3.9%newsSeeking AlphaKorro Bio: Promising Early Stage RNA Editing Company
2026-04-10+3.8%newsGlobeNewswireKorro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-04-10+3.8%newsStock TitanNew Korro Bio hire gets stock option for 15,000 shares under Nasdaq rule - Stock Titan
2026-04-16+3.7%newsGlobeNewswireKorro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
2026-04-16+3.7%newsStock TitanKorro Bio (KRRO) outlines 2026 virtual meeting, director elections and pay vote - Stock Titan
2026-04-16+3.7%newsStock TitanKorro brings ammonia and liver disease data to 4 spring conferences - Stock Titan
2024-01-20+3.2%newsCoinCodexKorro Bio, Inc. (KRRO) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2024-07-01-3.1%newsSeeking AlphaKorro Bio joins Russell 2000, Russell 3000, Russell Microcap indexes
2025-05-07+3.0%earningsSeeking AlphaKorro Bio GAAP EPS of -$2.49, revenue of $2.55M
2025-05-07+3.0%newsIntellectia AIKRRO Forecast — Price Prediction for 2026. Should I Buy KRRO? - Intellectia AI
2024-04-18-2.6%legalSeeking AlphaKorro secures $70M financing via private placement
2024-04-18-2.6%expansionSeeking AlphaKorro Bio launches $70M PIPE offering
2024-12-23-2.6%analystSeeking AlphaKorro Bio: Still Too Long To Go... Just Keep Watching For Now (Rating Upgrade)
2024-04-19+2.4%analysteToroKRRO Stock Price | Analyst Target 22.60 & Consensus - eToro
2025-11-16+2.2%analystGenetic Engineering and Biotechnology NewsStockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia - Genetic Engineering and Biotechnology News
2026-01-30-2.2%newsYahoo FinanceStrength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? - Yahoo Finance
2026-04-03-2.0%analystGuruFocusKRRO Receives Upgraded Analyst Rating and Price Target Boost fro - GuruFocus
2026-03-09+2.0%expansionMT NewswiresKorro Bio Enters Subscription Agreement for $85 Million Private Placement
2026-03-09+2.0%newsGlobeNewswireKorro Announces Oversubscribed $85 Million Private Placement
2026-03-09+2.0%newsSeeking AlphaKorro announces oversubscribed $85 million private placement
2026-03-09+2.0%newsStock TitanInvestors pour $85M into RNA editor Korro Bio’s genetic disease drugs - Stock Titan
2026-03-09+2.0%newsTradingViewKorro Bio Raises $85 Million in Private Placement, Adds Investor Registration Rights - TradingView
2026-03-09+2.0%newsInvesting.comKorro Bio raises $85 million in private equity financing - Investing.com
2023-11-26-1.8%earningsTradingViewKorro Bio, Inc. Earnings and Revenue – NASDAQ:KRRO - TradingView
2024-06-02-1.7%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Korro Bio, Inc. (KRRO) - Zacks Investment Research
2024-05-15+1.4%earningsSeeking AlphaKorro Bio reports Q1 GAAP EPS of -$2.44
2024-05-15+1.4%analystTradingViewKRRO Forecast — Price Target — Prediction for 2027 - TradingView
2025-03-14-1.2%legalSeeking AlphaKorro Bio gets Orphan Drug Designation from FDA for its genetic disorder treatment
2026-04-06-1.2%earningsMarketBeatTop 5 Insider Buys From Q1: Buy, Sell, or Hold in Q2?
2026-04-06-1.2%newsCổng thông tin điện tử tỉnh Lào CaiIs Korro Bio (KRRO) Stock Trending Up | Price at $14.83, Up 5.93% - Debt Free Stocks - Cổng thông tin điện tử tỉnh Lào Cai
2026-02-25+1.1%newsStock TitanRNA medicine developer Korro to present at three-day Boston health conference - Stock Titan
2026-02-26+1.0%earningsZacksCollegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
2024-04-25-0.7%newsZacks Investment ResearchShould I buy Korro Bio, Inc. (KRRO) - Zacks Investment Research
tickerdossier.comtickerdossier.substack.com